Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Esomeprazole hemistrontium

Copy Product Info
😃Good
Catalog No. T61740Cas No. 914613-86-8

Esomeprazole hemistrontium, also known as (S)-Omeprazole, is a potent and orally active proton pump inhibitor that effectively reduces acid secretion by inhibiting the H+, K+-ATPase in gastric parietal cells. This compound exhibits promising potential for research in symptomatic gastroesophageal reflux disease [1] [2] [3].

Esomeprazole hemistrontium

Esomeprazole hemistrontium

Copy Product Info
😃Good
Catalog No. T61740Cas No. 914613-86-8
Esomeprazole hemistrontium, also known as (S)-Omeprazole, is a potent and orally active proton pump inhibitor that effectively reduces acid secretion by inhibiting the H+, K+-ATPase in gastric parietal cells. This compound exhibits promising potential for research in symptomatic gastroesophageal reflux disease [1] [2] [3].
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
25 mg$1,5201-2 weeks1-2 weeks
50 mg$1,9801-2 weeks1-2 weeks
100 mg$2,5001-2 weeks1-2 weeks
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Resource Download

Product Introduction

Bioactivity
Description
Esomeprazole hemistrontium, also known as (S)-Omeprazole, is a potent and orally active proton pump inhibitor that effectively reduces acid secretion by inhibiting the H+, K+-ATPase in gastric parietal cells. This compound exhibits promising potential for research in symptomatic gastroesophageal reflux disease [1] [2] [3].
In vitro
Esomeprazole (25-100 μM; 20 hours; MDA-MB-468 cells) treatment suppresses the growth of triple-negative breast cancer cells in vitro in a dose-dependent manner through increased intracellular acidification [1].
In vivo
Esomeprazole administered via oral gavage at doses ranging from 30 to 300 mg/kg daily for 11 to 19 days significantly reduces lung fibrosis progression in C57BL/6J mice subjected to cotton smoke-induced lung injury. Additionally, this treatment lowers markers of inflammation and fibrosis in circulation. This study involved 8-week-old C57BL/6J mice weighing between 25-30 g.
Chemical Properties
Molecular Weight776.44
FormulaC34H36N6O6S2Sr
Cas No.914613-86-8
Smiles[Sr++].COc1ccc2[n-]c(nc2c1)S(=O)Cc1ncc(C)c(OC)c1C.COc1ccc2[n-]c(nc2c1)S(=O)Cc1ncc(C)c(OC)c1C
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: buy Esomeprazole hemistrontium | purchase Esomeprazole hemistrontium | Esomeprazole hemistrontium cost | order Esomeprazole hemistrontium | Esomeprazole hemistrontium chemical structure | Esomeprazole hemistrontium in vivo | Esomeprazole hemistrontium in vitro | Esomeprazole hemistrontium formula | Esomeprazole hemistrontium molecular weight